C145H138Cl2F3N21O20 — CID 158200111
3-chloro-N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]benzamide;5-[4-(4-chlorophenyl)-3-oxobutyl]-2-methyl-3-(4-methylidene-2-oxocyclohexyl)quinazolin-4-one;2-methyl-3-(4-methylidene-2-oxocyclohexyl)-5-(3-oxo-4-phenylbutyl)quinazolin-4-one;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]pyridine-2-carboxamide;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide;N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]-2-phenylmethoxyacetamide (PubChem CID 158200111) has the molecular formula C145H138Cl2F3N21O20 and a molecular weight of 2622.73 g/mol. Its IUPAC name is 3-chloro-N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]benzamide;5-[4-(4-chlorophenyl)-3-oxobutyl]-2-methyl-3-(4-methylidene-2-oxocyclohexyl)quinazolin-4-one;2-methyl-3-(4-methylidene-2-oxocyclohexyl)-5-(3-oxo-4-phenylbutyl)quinazolin-4-one;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]pyridine-2-carboxamide;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide;N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]-2-phenylmethoxyacetamide.
| Compound Name | 3-chloro-N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]benzamide;5-[4-(4-chlorophenyl)-3-oxobutyl]-2-methyl-3-(4-methylidene-2-oxocyclohexyl)quinazolin-4-one;2-methyl-3-(4-methylidene-2-oxocyclohexyl)-5-(3-oxo-4-phenylbutyl)quinazolin-4-one;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]pyridine-2-carboxamide;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide;N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]-2-phenylmethoxyacetamide |
|---|---|
| PubChem CID | 158200111 |
| Molecular Formula | C145H138Cl2F3N21O20 |
| Molecular Weight | 2622.73 g/mol |
| Exact Mass | 2619.98 |
| IUPAC Name | 3-chloro-N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]benzamide;5-[4-(4-chlorophenyl)-3-oxobutyl]-2-methyl-3-(4-methylidene-2-oxocyclohexyl)quinazolin-4-one;2-methyl-3-(4-methylidene-2-oxocyclohexyl)-5-(3-oxo-4-phenylbutyl)quinazolin-4-one;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]pyridine-2-carboxamide;N-[[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]methyl]-2-[4-(trifluoromethoxy)phenyl]acetamide;N-[2-methyl-3-(6-methylidene-2-oxopiperidin-3-yl)-4-oxoquinazolin-5-yl]-2-phenylmethoxyacetamide |
| SMILES | C=C1CCC(n2c(C)nc3cccc(CCC(=O)Cc4ccc(Cl)cc4)c3c2=O)C(=O)C1.C=C1CCC(n2c(C)nc3cccc(CCC(=O)Cc4ccccc4)c3c2=O)C(=O)C1.C=C1CCC(n2c(C)nc3cccc(CNC(=O)Cc4ccc(OC(F)(F)F)cc4)c3c2=O)C(=O)N1.C=C1CCC(n2c(C)nc3cccc(CNC(=O)c4ccccn4)c3c2=O)C(=O)N1.C=C1CCC(n2c(C)nc3cccc(NC(=O)COCc4ccccc4)c3c2=O)C(=O)N1.C=C1CCC(n2c(C)nc3cccc(NC(=O)c4cccc(Cl)c4)c3c2=O)C(=O)N1 |
| InChI | InChI=1S/C26H25ClN2O3.C26H26N2O3.C25H23F3N4O4.C24H24N4O4.C22H19ClN4O3.C22H21N5O3/c1-16-6-13-23(24(31)14-16)29-17(2)28-22-5-3-4-19(25(22)26(29)32)9-12-21(30)15-18-7-10-20(27)11-8-18;1-17-11-14-23(24(30)15-17)28-18(2)27-22-10-6-9-20(25(22)26(28)31)12-13-21(29)16-19-7-4-3-5-8-19;1-14-6-11-20(23(34)30-14)32-15(2)31-19-5-3-4-17(22(19)24(32)35)13-29-21(33)12-16-7-9-18(10-8-16)36-25(26,27)28;1-15-11-12-20(23(30)25-15)28-16(2)26-18-9-6-10-19(22(18)24(28)31)27-21(29)14-32-13-17-7-4-3-5-8-17;1-12-9-10-18(21(29)24-12)27-13(2)25-16-7-4-8-17(19(16)22(27)30)26-20(28)14-5-3-6-15(23)11-14;1-13-9-10-18(21(29)25-13)27-14(2)26-16-8-5-6-15(19(16)22(27)30)12-24-20(28)17-7-3-4-11-23-17/h3-5,7-8,10-11,23H,1,6,9,12-15H2,2H3;3-10,23H,1,11-16H2,2H3;3-5,7-10,20H,1,6,11-13H2,2H3,(H,29,33)(H,30,34);3-10,20H,1,11-14H2,2H3,(H,25,30)(H,27,29);3-8,11,18H,1,9-10H2,2H3,(H,24,29)(H,26,28);3-8,11,18H,1,9-10,12H2,2H3,(H,24,28)(H,25,29) |
| InChIKey | GAVDOQJLWGIFHX-UHFFFAOYSA-N |
| XLogP | 21.08 |
| TPSA | 541.77 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 191 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2622.73 |
| LogP ≤ 5 | 21.08 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 33 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|